Mont. Admin. r. 24.174.1401

Current through Register Vol. 23, December 6, 2024
Rule 24.174.1401 - REQUIREMENTS FOR REGISTRATION
(1) The board shall register a person to manufacture dangerous drugs (as defined in 50-32-101, MCA) included in Schedules I through V upon the following conditions:
(a) applicant is registered for such purposes pursuant to the Federal Controlled Substances Act of 1970;
(b) the applicant has made proper application and has paid the applicable fee; and
(c) the category of manufacturer as above-stated shall include only those applicants who are engaged in the manufacturing of dangerous drugs within the state of Montana.
(2) The board shall register a person or entity to distribute dangerous drugs included in Schedules I through V under the following conditions:
(a) applicant is registered for such purpose pursuant to the Federal Controlled Substances Act of 1970;
(b) the applicant has made proper application and paid the applicable fee;
(c) the category of distributor as above-stated shall include any person or entity who distributes dangerous drugs or samples thereof within the state of Montana and may include a manufacturer not otherwise required to be registered if such manufacturer also distributes dangerous drugs or samples thereof within the state of Montana; and
(d) representatives of drug manufacturers who distribute controlled substance samples to licensed practitioners shall be exempt from the requirement of registration.
(3) The board shall register a person to analyze or conduct research with narcotic dangerous drugs in Schedules II through V upon making proper application and paying the applicable fee.
(4) The board shall register a person to analyze or conduct research with dangerous drugs in Schedule I, if:
(a) the applicant is a practitioner licensed under the laws of this state;
(b) the applicant has furnished the board evidence of registration for such purpose pursuant to the Federal Controlled Substances Act of 1970;
(c) the applicant has furnished the board a complete resume of all research proposed relative to any dangerous drugs. Such resume must be a duplicate of an application submitted to the DEA; and
(d) the applicant has made proper application and paid the applicable fee.

Mont. Admin. r. 24.174.1401

NEW, Eff. 8/4/74; AMD, Eff. 2/4/75; AMD, Eff. 12/5/75; AMD, 1980 MAR p. 126, Eff. 1/18/80; TRANS, from Dept. of Prof. & Occup. Lic., Ch. 274, L. 1981, Eff. 7/1/81; AMD, 1998 MAR p. 3103, Eff. 11/20/98; AMD, 2002 MAR p. 178, Eff. 2/1/02; TRANS, from Commerce, 2002 MAR p. 904; AMD, 2006 MAR p. 1615, Eff. 6/23/06.

50-32-103, MCA; IMP, 50-32-306, 50-32-308, MCA;